CEO Total Pay
$21.9M
FY2025 Summary Compensation, well above median
The CEO earned $21.9M in FY2025 against median worker pay of $167,191 · Chemicals & Pharmaceuticals.
Data updated August 2026
Subscribe to Bristol Myers Squibb Co CEO pay filing updates (RSS)
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $167,191. Industry placement uses the FY2025 SIC-28 peer cohort (# 31 of 168, 82nd percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
Bristol Myers Squibb Co CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$21,902,021 Top 10% higher than 90% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($21.9M) against pay ratio (131:1) for Bristol Myers Squibb Co (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Bristol Myers Squibb Co's structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $19.8M | - | $148,649 | 133:1 | - |
| 2022 | $20.0M | +1.1% | $149,162 | 134:1 | +1:1 |
| 2023 | $19.7M | -1.6% | $151,172 | 130:1 | -4:1 |
| 2024 | $18.7M | -4.7% | $160,144 | 117:1 | -13:1 |
| 2025 | $21.9M | +17% | $167,191 | 131:1 | +14:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 14272, FY2021–2025. Adjacent-year deltas only.
Bristol Myers Squibb Co's FY2025 ratio 131:1 ranks #31 of 168 Chemicals & Pharmaceuticals filers (82nd percentile). the CEO earned 131× the median employee ($167,191) in FY2025.
Median employee $167,191 (ELITE-MED); MID · PEAK stamps put about 131 median-wage years per CEO year.
CEO Total Pay
$21.9M
FY2025 Summary Compensation, well above median
Pay Ratio
131:1
Near industry median
Bristol Myers Squibb Co's FY2025 ratio 131:1 ranks #31 of 168 Chemicals & Pharmaceuticals filers (82nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Bristol Myers Squibb Co's $21.9M CEO total is above the $7.9M industry median CEO pay.
Dollar rank #146 and ratio rank #494 split - treat 131:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.
Read our methodology - how this data is sourced, computed, and verified. Bristol Myers Squibb Co's FY2025 ratio 131:1 ranks #31 of 168 Chemicals & Pharmaceuticals filers (82nd percentile).
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · PEAK · ELITE-MED.
ABS(ceo_total_comp) peer at $21.9M (Δ $26K heavier vs Bristol Myers Squibb Co); MID · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
ABS(ceo_total_comp) peer at $22.0M (Δ $60K heavier vs Bristol Myers Squibb Co); FLOOR · PAR-MED vs this page's MID · PEAK · ELITE-MED.
ABS(ceo_total_comp) peer at $21.8M (Δ $102K lighter vs Bristol Myers Squibb Co); STEEP · HIGH-MED vs this page's MID · PEAK · ELITE-MED.
ABS(ceo_total_comp) peer at $21.8M (Δ $124K lighter vs Bristol Myers Squibb Co); HIGH · PAR-MED vs this page's MID · PEAK · ELITE-MED.
Axalta Coating Systems Ltd. stamps MID · HEAVY nearest in-SIC by ABS(pay_ratio) to Bristol Myers Squibb Co's MID filing.
Bristol Myers Squibb Co's FY2025 package sits #146 by CEO dollars and #494 by ratio under PEAK · MID.
Bristol Myers Squibb Co's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.